Planet DDS | August 12, 2022
Planet DDS, the leading provider of cloud-based dental software, announced the acquisition of QSIDental from NextGen Healthcare, Inc. QSIDental offers cloud-based dental practice management software and has been a trusted clinical software partner to dental organizations for 40 years.
This acquisition, including QSIDental Web®, reinforces the company’s commitment to cloud-based solutions as a way for dental practices to navigate and uncover new opportunities through unprecedented times in the industry. Planet DDS will actively support the needs of existing QSIDental customers, empowering their growth and success through industry-leading cloud solutions.
“With rising costs and a difficult hiring environment, these are challenging times for dental practices. Planet DDS is committed to helping our customers to be more efficient and reduce costs while delivering better patient care. This acquisition enhances our ability to deliver top-rated cloud-based software to more dental practices across North America, and we are excited to welcome QSIDental team members and customers into the Planet DDS family.”
Eric Giesecke, CEO of Planet DDS
Planet DDS and QSIDental share similar philosophies on the use of technology to deliver more efficient workflows for dental practices, maximize quality of care, and enhance the patient experience.
About Planet DDS
Planet DDS is the leading provider of cloud-enabled dental software solutions serving over 10,000 practices in North America with over 60,000 users. The company delivers a complete platform of solutions for dental practices including Denticon Practice Management, Apteryx XVWeb Digital Imaging, and Legwork Patient Relationship Management. Planet DDS is committed to creating value for its dental practice clients by solving the most urgent challenges facing today’s dental practices in North America.
Axonics, Inc. | August 18, 2022
Axonics, Inc. a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, announced that in the last twelve months, the United States Patent and Trademark Office has granted eight patents and allowed four patent applications related to the company’s sacral neuromodulation technology.
The patents and allowed applications are part of Axonics’ patent portfolio and represents technology internally developed by the company covering a range of subject matter that includes the Axonics external trial system, tined lead, implantable neurostimulator, clinician programmer, wireless charging system and patient remote control.
“Axonics is committed to developing best-in-class technology to serve the unmet needs of the millions of adults suffering from incontinence. The volume, subject matter diversity, and breadth of these patents demonstrate the investment in innovation that Axonics continues to make in sacral neuromodulation technology,”
Raymond W. Cohen, chief executive officer
Based in Irvine, Calif., Axonics is a global medical technology company that is developing and commercializing novel products for adults with bladder and bowel dysfunction. Axonics recently ranked No. 1 on the 2021 Deloitte Technology Fast 500™ and the 2022 Financial Times ranking of the 500 fastest growing companies in the Americas.
Axonics sacral neuromodulation (SNM) systems provide adults suffering from overactive bladder and/or fecal incontinence with long-lived, easy to use, safe, clinically effective therapy. In addition, the company’s best-in-class urethral bulking hydrogel, Bulkamid®, provides safe and durable symptom relief to women with stress urinary incontinence (SUI). Overactive bladder affects an estimated 87 million adults in the U.S. and Europe, with an additional 40 million adults estimated to suffer from fecal incontinence. SUI affects an estimated 29 million women in the U.S. alone. Axonics’ clinically proven products are offered at hundreds of medical centers across the U.S. and abroad. Reimbursement coverage is well established in the U.S. and is a covered service in most European countries.
Sameday Health | August 16, 2022
Sameday Health, a world-class testing and wellness provider, announced the rollout of strep and flu testing across participating Sameday Health clinics nationwide, including in California, New York, and Washington D.C. The new tests are offered individually and in bundles, giving clients the opportunity to receive strep, flu and COVID-19 tests together for a discounted price.
Each year, strep throat and the flu affect millions of Americans. According to the CDC, up to 25,000 cases of invasive "group A" strep disease occur annually in the United States. The CDC also estimates that last year's flu season caused up to 13 million related illnesses and 6.1 million medical visits.
Particularly with back-to-school season on the horizon, strep and flu testing services will become more critical to keep communities healthy.
"At Sameday Health, we've intentionally spent the past year bolstering our infrastructure to enable the expansion of our diagnostic testing services and further safeguard the health of our communities. We're proud to facilitate better health outcomes for our clients by offering services, now including strep and flu testing, that deliver peace of mind and the information they need to lead healthier, fuller lives."
Felix Huettenbach, Sameday Health CEO and Founder
"As common viruses and infections reemerge during the fall months – on top of new COVID-19 variants – it's important to quickly receive clarity on whether a condition is strep, flu, COVID-19, or another illness," Patrick Emad, Sameday Health's Executive Vice President of Clinics. "Our comprehensive testing helps to minimize the spread of illnesses, boost proper diagnoses, and expedite symptom relief."
Sameday Health's strep and flu testing joins their other reliable and convenient same-day medical services, including COVID-19 testing, panel testing, IV drip therapy, wellness injections, and urgent care.
About Sameday Health
Sameday Health is dedicated to healthcare as a complete experience, not simply a service. Our purpose is to create healthcare that centers around the client, combining a human approach with intuitive technology. We offer quality, personalized care wherever you are including in our clinics or at your door.
Inspired by the lotus flower's ability to grow in even the toughest terrains, Sameday Health is determined to create a sense of hope and help with our clients. Since opening our first clinic in Venice, CA at the height of the COVID 19-pandemic, the Sameday team has been focused on closing gaps in the healthcare system from testing to wellness to care. Devoted to responding immediately to our client's needs, we are providing expanded same day healthcare in our locations including Los Angeles, San Francisco, New York, Miami, DC, Boston, and more.